Sanofi US News

- All six trials met primary efficacy endpoint -

IcyHot SmartRelief System Provides Physical Therapist-Trusted TENS Technology for Persistent, Chronic Back Pain Relief That Starts at the Touch of a Button

- Dupilumab Demonstrated Improvement in Lung Function, Reductions of Severe Exacerbations -

- Includes New Data Showing Fluzone High-Dose Vaccine More Efficacious Than Standard-Dose Fluzone Vaccine -

The two companies will develop a product jointly through phase II

More Than $83,000 Raised Benefiting Boys & Girls Clubs of NEPA, Employment Opportunity and Training Center, and Marley’s Mission

- Up to $200 Million Collaboration to Support Pioneering Science and New Treatments -

Approval aligns with Centers for Disease Control and Prevention's recommendations for meningococcal vaccination

- Alirocumab, an investigational treatment for hypercholesterolemia, showed a 62 percent reduction in LDL-C compared to placebo at 24 weeks on top of maximally-tolerated lipid-lowering therapy in ODYSSEY LONG TERM trial -

- Study Demonstrates Fluzone High-Dose Vaccine 24.2 Percent More Effective Than Standard-Dose Fluzone Vaccine in Preventing Influenza in Adults 65 Years of Age and Older -

- Study Demonstrates Fluzone High-Dose Vaccine 24.2 Percent More Effective Than Standard-Dose Fluzone Vaccine in Preventing Influenza in Adults 65 Years of Age and Older -

Generics Division of Sanofi, Winthrop US, to Market the Drug

- Primary efficacy endpoints met in all nine new trials of investigational PCSK9 inhibitor -

- Largest U.S. influenza vaccine supplier, providing broad product portfolio, will distribute at least 65 million doses to help protect people across multiple age groups against the virus this season -

- Results from Earlier Clinical Trials Published Today in the New England Journal of Medicine –

- Toujeo dossier already accepted by EMA -

-- Real World Outcome Study of Patients with Type 2 Diabetes Presented at American Diabetes Association 74th Scientific Sessions --

- Meta-analysis of three late-stage trials in people with type 2 diabetes shows decreases in risk of low blood sugar events of up to 31% at night-time compared with Lantus® -

During the 1-year program, patients showed statistically significant reductions in blood glucose levels, increased belief in their ability to self-manage their diabetes and improved perceptions of support, while the community showed statistically significant increases in diabetes awareness

- Initial focus on insulin-device combinations and care management services -

For Millions Of Sufferers, Heartburn Can Be Spelled Many Different Ways But Relief Can Always Be Spelled R-O-L-A-I-D-S

Results indicate vaccine generates an immune response against key toxins in volunteers and establish dosing for Phase III

- What's Your AQ? Answers Common Anaphylaxis Questions During National Asthma and Allergy Awareness Month -

$100,000 prize and access to additional expertise awarded to support "big data" genetic analysis to provide new clues to the higher incidence of ALS in veterans

Olympic Medalist swimmer and mother, Dara Torres, and the National Association of School Nurses launch multi-city health initiative as part of Voices of Meningitis™

Nasal allergy sufferers now have the most effective player on their team to relieve even the toughest nasal allergy symptoms

New investigational PCSK9 inhibitor shown to significantly reduce LDL-C among Japanese patients

Approval reinforces the safety profile of Adacel as an active booster immunization for the prevention of tetanus, diphtheria, and pertussis

Companies to Host Investor Conference Call on Alirocumab on March 31 at 9 AM EDT

Fewer Moms are Aware of Prescription Treatments for Head Lice Compared to OTC Yet Those Who Used an Rx Report Greater Satisfaction

First and only medicine in its class approved for over-the-counter use that provides 24 hour relief of the full range of nasal allergy symptoms including nasal congestion

Pathway to Stop Diabetes will provide funding for innovative diabetes researchers

- Collaboration represents the first time the ACC’s PINNACLE Registry Research Alliance will be used for clinical trial recruitment -

Developing approaches for involving patients in drug development

- Similar glucose lowering effect when once-daily Lyxumia is administered before breakfast or the main meal -

- EDITION II trial demonstrates similar blood sugar control with fewer night-time low blood sugar events for U300 compared with Lantus® -

- Sarilumab, Given Subcutaneously Every Other Week, Met All Three Co-Primary Endpoints -

- Nasal Spray Treats Adults and Children with Seasonal and Year-Round Nasal Allergies -

Event Builds on Tradition of Corporate Citizenship and Community

New online resource provides customized tools, resources developed by leading Grandparent Expert to help grandparents learn more about highly contagious, often serious disease

- Findings Consistent with Known Post-Prandial Effect of Lyxumia Supporting Combination with Basal Insulin -

Campaign harnesses positive peer influence and power of social media to help drive flu vaccination among #FLUgitives

-- Addition of Iconic Brand Bolsters U.S. Consumer Healthcare Business --

- Efficacy trial in more than 30,000 older adults meets primary endpoint for superior efficacy -

- Majority of Survey Respondents Reported They or Their Child Experienced a Severe Allergic Reaction While Traveling -

Cdiffense trial to evaluate vaccine against a leading cause of life-threatening, healthcare-associated infections worldwide

- Treats Seasonal and Year-round Nasal Allergy Symptoms in Adults and Children -

- Largest supplier of influenza vaccine in U.S., first to ship, will distribute more than 60 million doses of flu vaccines for fall immunization campaigns -

- EDITION I demonstrated similar blood sugar control with fewer night-time low blood sugar events compared to Lantus® -

-- Lixisenatide decreased HbA1c by reducing PPG when added to basal insulin with or without oral anti-diabetic agents --

- Headfirst! Expert Advice on Lice Offers Moms and Healthcare Providers Helpful Tools and Resources to Overcome Head Lice -

- "Get in the Game" urges parents to take action and vaccinate against meningococcal disease in advance of the upcoming sports season

New Fluzone® Quadrivalent (Influenza Virus Vaccine):

Campaign Continues to Educate Adults on How to Help Protect Themselves and How to Help Stop the Spread of Pertussis to Infants

- Connect & Coach™ Awarded $100,000 to Further Develop its Novel Solution to Help Improve Health Outcomes for People Living with Diabetes -

- Bettis Unveils New Playbook for Defending Against Severe Allergic Reactions and Urges Those Affected to Take Action -

The same trusted formula in an easy aim spray

-Donation to Diabetes Hands Foundation Doubled When Documentary Reaches 10,000 Views-

Growth platforms(2) sales increased 8.6%(3)

Donation to fund instrumentation and scholarships for university science and technology programs

Over-the-Counter Allergy Brand Now Offers Topical Relief for Itchy, Dry Skin Just in Time for Summer

Game On! Leslie and Sanofi's Chattem Encourage Families to Put Seasonal Allergies Behind Them and Stay Active This Spring

National Patient Spokesperson Melanie Bloom Commemorates Significant Achievements to Raise Awareness of DVT and Potentially Fatal Complication, Pulmonary Embolism

Pathway to Stop Diabetes to provide funding for innovative diabetes researchers

- Sanofi US to Donate Up to $100,000 to Patient Organizations -

- Bettis and Miller, Both at Risk for Anaphylaxis, Join Forces with Sanofi US to Introduce Auvi-Q (Epinephrine Injection, USP) and Serve Up Allergy-Friendly Tips for Big Game Parties -

--LeGoo® proprietary gel technology provides clear surgical field for cardiothoracic and vascular surgeons without trauma to blood vessels--

-- Breakthrough device design talks patients and caregivers through the injection process --

- NBA All-Stars Andre Iguodala and Danny Granger and Seven-Time WNBA All-Star Tamika Catchings to Help Raise Awareness about Diabetes -

-- Product acquisition further strengthens Consumer Healthcare Division of Sanofi US --

- Company’s annual Adopt-a-Family drive delivers essential items to local families in need -

- Registries for All Diseases wins $300k to create crowdsourced cross-disease registry -

Pathway to Stop Diabetes to Provide Funding for Innovative Diabetes Researchers

- New Data Presented at American Society of Hematology Annual Meeting Show Activity Against Disease and Symptom Alleviation -

Response Includes Contribution to Three New Jersey Area Organizations